Kimberly E Lind1, Eric J Gutierrez2, Dorothy J Yamamoto3, Michael F Regner3, Sherry A McKee4, Jody Tanabe5. 1. Department of Radiology, University of Colorado School of Medicine, Aurora, CO, USA; Departments of Health Systems, Management and Policy, University of Colorado School of Public Health, Aurora, CO, USA. 2. Biostatistics and Informatics, University of Colorado School of Public Health, Aurora, CO, USA. 3. Department of Radiology, University of Colorado School of Medicine, Aurora, CO, USA. 4. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. 5. Department of Radiology, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: jody.tanabe@ucdenver.edu.
Abstract
BACKGROUND: Sex differences in brain structure and clinical course of substance use disorders underscores the need to include women in structural brain imaging studies. The NIH has supported the need for research to address sex differences. We evaluated female enrollment in substance abuse structural brain imaging research and the methods used to study sex differences in substance effects. METHODS: Structural brain imaging studies published through 2016 (n=230) were evaluated for number of participants by sex and substance use status and methods used to evaluate sex differences. Temporal trends in the numbers of participants by sex and substance use status were analyzed. We evaluated how often sex effects were appropriately analyzed and the proportion of studies that found sex by substance interactions on volumetric measures. RESULTS: Female enrollment increased over time, but remained significantly lower than male enrollment (p=0.01), with the greatest bias for alcohol and opiate studies. 79% of studies included both sexes; however, 74% did not evaluate sex effects or used an analytic approach that precluded detection of sex by substance use interactions. 85% of studies that stratified by sex reported different substance effects on brain volumes. Only 33% of studies examining two-way interactions found significant interactions, highlighting that many studies were underpowered to detect interactions. CONCLUSIONS: Although female participation in substance use studies of brain morphometry has increased, sex disparity persists. Studying adequate numbers of both sexes and employing correct analytic approaches is critical for understanding sex differences in brain morphometric changes in substance abuse.
BACKGROUND: Sex differences in brain structure and clinical course of substance use disorders underscores the need to include women in structural brain imaging studies. The NIH has supported the need for research to address sex differences. We evaluated female enrollment in substance abuse structural brain imaging research and the methods used to study sex differences in substance effects. METHODS: Structural brain imaging studies published through 2016 (n=230) were evaluated for number of participants by sex and substance use status and methods used to evaluate sex differences. Temporal trends in the numbers of participants by sex and substance use status were analyzed. We evaluated how often sex effects were appropriately analyzed and the proportion of studies that found sex by substance interactions on volumetric measures. RESULTS: Female enrollment increased over time, but remained significantly lower than male enrollment (p=0.01), with the greatest bias for alcohol and opiate studies. 79% of studies included both sexes; however, 74% did not evaluate sex effects or used an analytic approach that precluded detection of sex by substance use interactions. 85% of studies that stratified by sex reported different substance effects on brain volumes. Only 33% of studies examining two-way interactions found significant interactions, highlighting that many studies were underpowered to detect interactions. CONCLUSIONS: Although female participation in substance use studies of brain morphometry has increased, sex disparity persists. Studying adequate numbers of both sexes and employing correct analytic approaches is critical for understanding sex differences in brain morphometric changes in substance abuse.
Authors: Rhoshel K Lenroot; Nitin Gogtay; Deanna K Greenstein; Elizabeth Molloy Wells; Gregory L Wallace; Liv S Clasen; Jonathan D Blumenthal; Jason Lerch; Alex P Zijdenbos; Alan C Evans; Paul M Thompson; Jay N Giedd Journal: Neuroimage Date: 2007-04-06 Impact factor: 6.556
Authors: Julio M Duarte-Carvajalino; Neda Jahanshad; Christophe Lenglet; Katie L McMahon; Greig I de Zubicaray; Nicholas G Martin; Margaret J Wright; Paul M Thompson; Guillermo Sapiro Journal: Neuroimage Date: 2011-11-12 Impact factor: 6.556
Authors: Marc N Potenza; Kwang-ik Adam Hong; Cheryl M Lacadie; Robert K Fulbright; Keri L Tuit; Rajita Sinha Journal: Am J Psychiatry Date: 2012-04 Impact factor: 18.112
Authors: Robert I Perry; Theodore Krmpotich; Laetitia L Thompson; Susan K Mikulich-Gilbertson; Marie T Banich; Jody Tanabe Journal: Drug Alcohol Depend Date: 2013-05-28 Impact factor: 4.492
Authors: Miriam T H Harris; Jordana Laks; Natalie Stahl; Sarah M Bagley; Kelley Saia; Wendee M Wechsberg Journal: Med Clin North Am Date: 2022-01 Impact factor: 5.456
Authors: Michael Windle; Joshua C Gray; Karlo Mankit Lei; Allen W Barton; Gene Brody; Steven R H Beach; Adrianna Galván; James MacKillop; Uraina S Clark; Lawrence H Sweet Journal: Drug Alcohol Depend Date: 2018-03-14 Impact factor: 4.492
Authors: Landhing M Moran; William J Kowalczyk; Karran A Phillips; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein; Kenzie L Preston Journal: Am J Drug Alcohol Abuse Date: 2018-04-11 Impact factor: 3.829
Authors: Sally Grace; Maria Gloria Rossetti; Nicholas Allen; Albert Batalla; Marcella Bellani; Paolo Brambilla; Yann Chye; Janna Cousijn; Anna E Goudriaan; Robert Hester; Kent Hutchison; Izelle Labuschagne; Reza Momenan; Rocio Martin-Santos; Peter Rendell; Nadia Solowij; Rajita Sinha; Chiang-Shan Ray Li; Lianne Schmaal; Zsuzsika Sjoerds; Chao Suo; Gill Terrett; Ruth J van Holst; Dick J Veltman; Murat Yücel; Paul Thompson; Patricia Conrod; Scott Mackey; Hugh Garavan; Valentina Lorenzetti Journal: Transl Psychiatry Date: 2021-03-04 Impact factor: 6.222
Authors: Maria Gloria Rossetti; Scott Mackey; Praveetha Patalay; Nicholas B Allen; Albert Batalla; Marcella Bellani; Yann Chye; Patricia Conrod; Janna Cousijn; Hugh Garavan; Anna E Goudriaan; Robert Hester; Rocio Martin-Santos; Nadia Solowij; Chao Suo; Paul M Thompson; Murat Yücel; Paolo Brambilla; Valentina Lorenzetti Journal: Transl Psychiatry Date: 2021-05-06 Impact factor: 6.222